Jeff Yass’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Buy
142,200
+44,200
+45% +$422K ﹤0.01% 7444
2026
Q1
$895K Buy
98,000
+45,800
+88% +$384K ﹤0.01% 8178
2025
Q4
$388K Buy
52,200
+34,400
+193% +$247K ﹤0.01% 9365
2025
Q3
$119K Sell
17,800
-29,400
-62% -$204K ﹤0.01% 11459
2025
Q2
$312K Sell
47,200
-13,100
-22% -$92.9K ﹤0.01% 10248
2025
Q1
$552K Sell
60,300
-27,400
-31% -$274K ﹤0.01% 8684
2024
Q4
$921K Sell
87,700
-76,400
-47% -$904K ﹤0.01% 7169
2024
Q3
$1.96M Buy
164,100
+33,100
+25% +$286K ﹤0.01% 5310
2024
Q2
$753K Sell
131,000
-30,000
-19% -$165K ﹤0.01% 7250
2024
Q1
$837K Sell
161,000
-13,700
-8% -$67K ﹤0.01% 7309
2023
Q4
$921K Sell
174,700
-12,000
-6% -$47.5K ﹤0.01% 7182
2023
Q3
$616K Buy
186,700
+43,200
+30% +$152K ﹤0.01% 7740
2023
Q2
$415K Buy
+143,500
New +$275K ﹤0.01% 8753
2022
Q4
Sell
-11,400
Closed -$80K 12479
2022
Q3
$80K Sell
11,400
-1,500
-12% -$11.7K ﹤0.01% 11879
2022
Q2
$88K Buy
+12,900
New +$132K ﹤0.01% 11583

Other funds holding BVS

Jeff Yass's BVS Position: Q2 2026 in Review

Jeff Yass reduced its Bioventus (BVS) stake by 17% in Q2 2026, selling an estimated $33.7K and leaving 17,692 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #12115.

Jeff Yass first reported a position in BVS in Q1 2021 and has held it in 13 quarters since. The position peaked at $1.51M in Q1 2024. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Jeff Yass held 17,692 shares of Bioventus worth $167K as of Q2 2026.
  • Jeff Yass sold 3,525 Bioventus shares in Q2 2026, an estimated $33.7K.
  • Bioventus made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12115 holding.
  • Jeff Yass first reported a position in Bioventus in Q1 2021 and has held it in 13 quarters since.
  • Jeff Yass's Bioventus position peaked at $1.51M in Q1 2024.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.